{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:02:16Z","timestamp":1768352536000,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020230","name":"Consejer\u00eda de Transformaci\u00f3n Econ\u00f3mica, Industria, Conocimiento y Universidades","doi-asserted-by":"publisher","award":["POSTDOC_21_00308"],"award-info":[{"award-number":["POSTDOC_21_00308"]}],"id":[{"id":"10.13039\/100020230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.phrs.2023.106962","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:41:22Z","timestamp":1697776882000},"page":"106962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach"],"prefix":"10.1016","volume":"197","author":[{"given":"Blanca","family":"Gavil\u00e1n-Carrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Soriano-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Diego","family":"Mediavilla-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Vargas-Hitos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2023.106962_bib1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2217\/pgs.12.25","article-title":"Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives","volume":"13","author":"Postmus","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.phrs.2023.106962_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106962_bib3","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/eurheartj\/ehaa582","article-title":"Statin intolerance: myths and facts","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2023.106962_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jcm9010022","article-title":"Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components","volume":"9","author":"Turner","year":"2020","journal-title":"J. Clin. Med."},{"issue":"17","key":"10.1016\/j.phrs.2023.106962_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy - European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.phrs.2023.106962_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017915","article-title":"Shared decisions: a qualitative study on clinician and patient perspectives on statin therapy and statin-associated side effects","volume":"9","author":"Ahmed","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106962_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcsm.12344","article-title":"Introducing the \u2018 Drucebo \u2019 effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions","volume":"9","author":"Penson","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"22","key":"10.1016\/j.phrs.2023.106962_bib8","first-page":"1","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"6736","author":"Blazing","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106962_bib9","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehaa574","article-title":"Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom","volume":"41","author":"Hopewell","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106962_bib10","doi-asserted-by":"crossref","unstructured":"Hou Q., Chen Y., Zhang Y., Pang C. Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials. Cardiovasc Drugs Ther [Internet]. 2022;(0123456789) Available from: https:\/\/doi.org\/10.1007\/s10557\u2013022-07405\u20130. doi:10.1007\/s10557\u2013022-07405\u20130.","DOI":"10.1007\/s10557-022-07405-0"},{"issue":"March","key":"10.1016\/j.phrs.2023.106962_bib11","article-title":"Molecular targets of statins and their potential side effects: Not all the glitter is gold","volume":"922","author":"Patel","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106962_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2022.09.001","article-title":"Assessment and management of statin-associated muscle symptoms (SAMS): a clinical perspective from the National Lipid Association","volume":"21","author":"Warden","year":"2022","journal-title":"J. Clin. Lipido"},{"issue":"5","key":"10.1016\/j.phrs.2023.106962_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2013.03.001","article-title":"Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education","volume":"7","author":"Wei","year":"2013","journal-title":"J. Clin. Lipido"},{"issue":"10059","key":"10.1016\/j.phrs.2023.106962_bib14","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the effi cacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phrs.2023.106962_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/clc.22975","article-title":"Understanding patient adherence and concerns with statins and medication discussions with physicians (ACTION): a survey on the patient perspective of dialogue with healthcare providers regarding statin therapy","volume":"41","author":"Brinton","year":"2018","journal-title":"Clin. Cardiol."},{"issue":"February","key":"10.1016\/j.phrs.2023.106962_bib16","article-title":"Statin therapy in athletes and patients performing regular intense exercise \u2013 position paper from the International Lipid Expert Panel (ILEP)","volume":"155","author":"Katsiki","year":"2020","journal-title":"Pharm. Res."},{"issue":"25","key":"10.1016\/j.phrs.2023.106962_bib17","first-page":"E1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/ AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"April","key":"10.1016\/j.phrs.2023.106962_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American association of clinical endocrinologists and American college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.phrs.2023.106962_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40279-019-01059-z","article-title":"Institutional guidelines for resistance exercise training in cardiovascular disease: a systematic review","volume":"49","author":"Fidalgo","year":"2019","journal-title":"Sport Med."},{"issue":"2","key":"10.1016\/j.phrs.2023.106962_bib20","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1097\/HCR.0000000000000696","article-title":"Working toward optimal exercise prescription: strength training should not be overlooked","volume":"42","author":"Kaminsky","year":"2022","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"issue":"September","key":"10.1016\/j.phrs.2023.106962_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41569-021-00547-y","article-title":"Sit less and move more for cardiovascular health: emerging insights and opportunities","volume":"18","author":"Dunstan","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10051","key":"10.1016\/j.phrs.2023.106962_bib22","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(16)30370-1","article-title":"Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women","volume":"388","author":"Ekelund","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106962_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.pec.2021.09.019","article-title":"Start with reducing sedentary behavior: a stepwise approach to physical activity counseling in clinical practice","volume":"105","author":"Dogra","year":"2022","journal-title":"Patient Educ. Couns."},{"issue":"3","key":"10.1016\/j.phrs.2023.106962_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2014.03.003","article-title":"NLA task force on statin safety - 2014 update","volume":"8","author":"Jacobson","year":"2014","journal-title":"J. Clin. Lipido"},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00421-020-04566-4","article-title":"Exercise-induced muscle damage: mechanism, assessment and nutritional factors to accelerate recovery","volume":"121","author":"Markus","year":"2021","journal-title":"Eur. J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106962_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib27","first-page":"429","article-title":"The interaction between statins and exercise: mechanisms and strategies to counter the musculoskeletal side effects of this combination therapy","volume":"15","author":"Deichmann","year":"2015","journal-title":"Ochsner J."},{"issue":"6","key":"10.1016\/j.phrs.2023.106962_bib28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00421-020-04360-2","article-title":"The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations","volume":"120","author":"Schweitzer","year":"2020","journal-title":"Eur. J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib29","first-page":"324","article-title":"Treatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responses","volume":"104","author":"Bonfim","year":"2015","journal-title":"Arq. Bras. Cardiol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106962_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/2047487317691874","article-title":"Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: a systematic review and meta-analysis","volume":"24","author":"Gui","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.phrs.2023.106962_bib31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br. J. Sports Med"},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bjsports-2022-106189","article-title":"Adherence to aerobic and muscle-strengthening activities guidelines: a systematic review and meta-analysis of 3.3 million participants across 31 countries","volume":"57","author":"Garcia-Hermoso","year":"2023","journal-title":"Br. J. Sport. Med."},{"issue":"5","key":"10.1016\/j.phrs.2023.106962_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1559827620912192","article-title":"Exercise is medicine","volume":"14","author":"Thompson","year":"2020","journal-title":"Am. J. Lifestyle Med."},{"key":"10.1016\/j.phrs.2023.106962_bib34","first-page":"e495","article-title":"Routine assessment and promotion of physical activity in healthcare settings a scientific statement from the American Heart Association","volume":"137","author":"Sallis","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.phrs.2023.106962_bib35","unstructured":"American College of Sports Medicine. Exercise is Medicine. [date unknown]; Available from: https:\/\/www.exerciseismedicine.org\/eim-in-action\/health-care\/resources\/rx-for-health-series\/."},{"key":"10.1016\/j.phrs.2023.106962_bib36","unstructured":"Gary Liguori. ACSM\u2019s Guidelines for Exercise Testing and Prescription. 11th ed. Lippincott Williams & Wilkins; 2017."},{"key":"10.1016\/j.phrs.2023.106962_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2022-001339","article-title":"Hierarchical framework to improve individualised exercise prescription in adults: a critical review","volume":"8","author":"Lehtonen","year":"2022","journal-title":"BMJ Open Sport Exerc. Med."},{"key":"10.1016\/j.phrs.2023.106962_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwad232","article-title":"Appropriate exercise prescription in primary and secondary prevention of cardiovascular disease: why this skill remains to be improved among clinicians and healthcare professionals. A call for action from the EXPERT Network","author":"Hansen","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106962_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","volume":"62","author":"Mikus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9864","key":"10.1016\/j.phrs.2023.106962_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(12)61426-3","article-title":"Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study","volume":"381","author":"Kokkinos","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.phrs.2023.106962_bib41","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.amjcard.2015.08.011","article-title":"Incident diabetes mellitus, hypertension, and cardiovascular disease risk in exercising hypercholesterolemic patients","volume":"116","author":"Williams","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106962_bib42","first-page":"68","article-title":"The creatine kinase response to resistance exercise","volume":"14","author":"Koch","year":"2014","journal-title":"J. Musculoskelet. Neuron Interact."},{"key":"10.1016\/j.phrs.2023.106962_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2017-000282","article-title":"Is it necessary to adjust current creatine kinase reference ranges to reflect levels found in professional footballers?","volume":"4","author":"Mahmutyazicioglu","year":"2018","journal-title":"BMJ Open Sport. Exerc. Med."},{"key":"10.1016\/j.phrs.2023.106962_bib44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjsm.2006.034041","article-title":"Reference intervals for serum creatine kinase in athletes","volume":"41","author":"Mougios","year":"2007","journal-title":"Br. J. Sport. Med."},{"issue":"19","key":"10.1016\/j.phrs.2023.106962_bib45","first-page":"344","article-title":"Creatine kinase levels after exercise","volume":"113","author":"Kindermann","year":"2016","journal-title":"Dtsch Arztebl Int."},{"issue":"7","key":"10.1016\/j.phrs.2023.106962_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.phrs.2023.106962_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib48","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","article-title":"Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems","volume":"57","author":"Sinzinger","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106962_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjcard.2011.08.045","article-title":"Effect of statins on creatine kinase levels before and after a marathon run","volume":"109","author":"Parker","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106962_bib50","article-title":"Rhabdomyolysis occurring under statins after intense physical activity in a marathon runner","volume":"2015","author":"Toussirot","year":"2015","journal-title":"Case Rep. Rheumatol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106962_bib51","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","article-title":"Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise","volume":"43","author":"Garber","year":"2011","journal-title":"Med. Sci. Sport. Exerc."},{"issue":"5","key":"10.1016\/j.phrs.2023.106962_bib52","article-title":"An update on the relationship between statins and physical activity","volume":"31","author":"Panza","year":"2016"},{"issue":"5","key":"10.1016\/j.phrs.2023.106962_bib53","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacl.2017.07.003","article-title":"The effects of statins on exercise and physical activity","volume":"11","author":"Noyes","year":"2017","journal-title":"J. Clin. Lipido"},{"issue":"10","key":"10.1016\/j.phrs.2023.106962_bib54","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.mayocp.2015.06.019","article-title":"Effects of statin therapy on exercise levels in participants in the national runners\u2019 and walkers\u2019 health study","volume":"90","author":"Williams","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2023.106962_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pcad.2022.11.010","article-title":"Statin associated muscle symptoms: an update and review","volume":"75","author":"Dicken","year":"2022","journal-title":"Prog. Cardiovasc Dis. 2022"},{"issue":"19","key":"10.1016\/j.phrs.2023.106962_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.118.009835","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: An updated meta-analysis of randomized controlled trials","volume":"7","author":"Qu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.phrs.2023.106962_bib57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2020.12.009","article-title":"Coenzyme Q10 for patients with cardiovascular disease: JACC focus seminar","volume":"77","author":"Raizner","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106962_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3810\/psm.2012.11.1991","article-title":"Impact of coenzyme Q-10 on parameters of cardiorespiratory fitness and muscle performance in older athletes taking statins","volume":"40","author":"Deichmann","year":"2013","journal-title":"Phys. Sport."},{"issue":"February","key":"10.1016\/j.phrs.2023.106962_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.03.006","article-title":"Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: a systematic review and meta-analysis","volume":"299","author":"Kennedy","year":"2020","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.phrs.2023.106962_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11845-021-02651-x","article-title":"Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials","volume":"191","author":"Wei","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.phrs.2023.106962_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2023.02.007","article-title":"PCSK9 inhibitor, ezetimibe, and bempedoic acid: evidence-based therapies for statin-intolerant patients","author":"Gunta","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2023.106962_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101714","article-title":"Management of patients with statin intolerance","volume":"37","author":"Martirossian","year":"2023","journal-title":"Best Pract. Res Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.phrs.2023.106962_bib63","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"New Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:52:11Z","timestamp":1760914331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823003183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":63,"alternative-id":["S1043661823003183"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106962","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106962"}}